Key clinical point: High-cost hospital stays among elderly patients with cancer are associated with comorbid conditions, major procedures, hematologic cancer, and metastatic cancer.
Major finding: On a cost basis, the top 10% of hospital visits were almost five times more expensive than the bottom 90% of hospital stays (median, $38,194 vs. $8,257).
Study details: A retrospective cost analysis of cancer-related inpatient visits among patients aged 65 years or older, with data from the 2014 National Inpatient Sample.
Disclosures: Novartis funded the study. Dr. Chavez-MacGregor reported financial relationships.
Avila et al. J Oncol Pract. 2019 Apr 4. doi: 10.1200/JOP.18.00706.